financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Keeps Hold Opinion On Adss Of Joyy Inc
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Keeps Hold Opinion On Adss Of Joyy Inc
May 29, 2024 2:30 AM

05:00 AM EDT, 05/29/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

Following JOYY's ( YY ) lower-than-expected Q1 2024 earnings, we cut our projected earnings per ADS for 2024/2025 to USD3.78/USD4.11 (from USD5.96/USD7.11), as we assume slower revenue growth and cost-outs. Our 12-month target price is cut to USD35 (from USD37), at 9.3x our projected 2024 earnings and a discount to its 3-year TTM average P/E of 15x. We believe this is appropriate given continuing uncertainties from the proposed cancelation of the acquisition of its former YY business by Baidu. We note that almost 25% of its cash balance is currently tied to the acquisition, being a share of the consideration received. In Q1 2024, revenue -3%, on lower live-streaming revenue as JOYY ( YY ) phased out non-core products for Bigo Live. Other revenues surged +55% on growth for the ads business. Operating income +40% to USD3.5 mln, as lower gross profit (-5%, higher revenue sharing fees) are offset by lower opex (-5%, from lower sales and R&D costs). JOYY ( YY ) expects revenue to be sequentially flat at best in Q2.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Retains Hold Opinion On Shares Of Biogen Inc.
Research Alert: CFRA Retains Hold Opinion On Shares Of Biogen Inc.
Apr 24, 2024
10:20 AM EDT, 04/24/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We trim our target $29 to $209, 12.5x our projected 2025 EPS, below BIIB's historical forward P/E average. After a better-than-anticipated Q1 EPS release, we raise our 2024 EPS view...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Evercore Inc
Research Alert: CFRA Maintains Buy Opinion On Shares Of Evercore Inc
Apr 24, 2024
10:05 AM EDT, 04/24/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our target by $2 to $216, on forward P/E of 14.4x our 2025 EPS estimate, in line with EVR's 10-year average multiple. We keep our 2024 EPS estimate...
Research Alert: CFRA Retains Buy Opinion On Shares Of Thermo Fisher Scientific Inc.
Research Alert: CFRA Retains Buy Opinion On Shares Of Thermo Fisher Scientific Inc.
Apr 24, 2024
09:45 AM EDT, 04/24/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Following a better-than-expected Q1 results announcement this morning, we lift our target price by $10 to $645, 26.6x our 2025 EPS view, slightly above TMO's five-year historical forward P/E average....
Research Alert: CFRA Keeps Hold Opinion On Shares Of Bunge Global Sa
Research Alert: CFRA Keeps Hold Opinion On Shares Of Bunge Global Sa
Apr 24, 2024
09:55 AM EDT, 04/24/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target to $105 from $93, 11x our '24 EPS of $9.50 (up from $9.26; '25's up to $10.76 from $10.44) vs. the 13x long-term mean. Q1...
Copyright 2023-2026 - www.financetom.com All Rights Reserved